IRulya Therapeutics (IRLA) Non-Current Assets (2018 - 2026)
IRulya Therapeutics' Non-Current Assets came in at $584,000 for Q2 2026, down 99.3% from $79.87 million a year earlier and down 44.0% from the prior quarter.
Powered by 
Analysis
IRulya Therapeutics (IRLA) Non-Current Assets (2018 - 2026) Analysis & Trends
At the end of FY2025, IRulya Therapeutics' Non-Current Assets was $70.63 million, up 0.3% from FY2024.
- Non-Current Assets carries a five-year compound annual growth rate of 6.5% (FY2020 to FY2025).
- Going back by year, Non-Current Assets was $70.44 million in FY2024 (-22.1%), $90.46 million in FY2023 (+790.2%), $10.16 million in FY2022 (-52.9%) and $21.56 million in FY2021 (-58.2%).
- The Q2 2026 figure represents the lowest quarterly Non-Current Assets since Q3 2023.
- Year-over-year, Non-Current Assets increased in three of the last seven quarters, with an average decline of 31.1%.
- The fastest year-over-year change in Non-Current Assets over five years came in Q4 2023 (growth of 790.2%), and the weakest in Q2 2026 (a decline of 99.3%).
- Business Quant data shows IRLA's Non-Current Assets at $1.04 million (Q1 2026), $70.63 million (Q4 2025) and $80.7 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 88.47 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 159.99 Bn |
| 10 | IRulya Therapeutics | 207.35 Mn | 91.35 Mn | - | 584,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 584,000.00 |
| Mar 31, 2026 | 1.04 Mn |
| Dec 31, 2025 | 70.63 Mn |
| Sep 30, 2025 | 80.70 Mn |
| Jun 30, 2025 | 79.87 Mn |
| Mar 31, 2025 | 73.26 Mn |
| Dec 31, 2024 | 70.44 Mn |
| Sep 30, 2024 | 74.80 Mn |
| Jun 30, 2024 | 71.39 Mn |
| Mar 31, 2024 | 88.85 Mn |
| Dec 31, 2023 | 90.46 Mn |
| Sep 30, 2023 | 213,000.00 |
| Jun 30, 2023 | 288,000.00 |
| Mar 31, 2023 | 827,000.00 |
| Dec 31, 2022 | 10.16 Mn |
| Sep 30, 2022 | 11.50 Mn |
| Jun 30, 2022 | 18.49 Mn |
| Mar 31, 2022 | 19.78 Mn |
| Dec 31, 2021 | 21.56 Mn |
| Sep 30, 2021 | 27.99 Mn |
API Access
IRulya Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=IRLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "IRLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=IRLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();